Production and application of HMGB1 derived recombinant RAGE-antagonist peptide for anti-inflammatory therapy in acute lung injury

Aman, 2011, Plasma protein levels are markers of pulmonary vascular permeability and degree of lung injury in critically ill patients with or at risk for acute lung injury/acute respiratory distress syndrome, Crit. Care Med., 39, 89, 10.1097/CCM.0b013e3181feb46a

Andersson, 2002, HMGB1 as a DNA-binding cytokine, J. Leukoc. Biol., 72, 1084, 10.1189/jlb.72.6.1084

Barnes, 1997, NF-kappa B: a pivotal role in asthma and a new target for therapy, Trends Pharmacol. Sci., 18, 46, 10.1016/S0165-6147(97)89796-9

von Bismarck, 2009, Selective NF-kappaB inhibition, but not dexamethasone, decreases acute lung injury in a newborn piglet airway inflammation model, Pulm. Pharmacol. Ther., 22, 297, 10.1016/j.pupt.2009.02.002

Blondonnet, 2017, RAGE inhibition reduces acute lung injury in mice, Sci. Rep., 7, 7208, 10.1038/s41598-017-07638-2

Fritz, 2011, RAGE: a single receptor fits multiple ligands, Trends Biochem. Sci., 36, 625, 10.1016/j.tibs.2011.08.008

Gong, 2009, Protective effect of antagonist of high-mobility group box 1 on lipopolysaccharide-induced acute lung injury in mice, Scand. J. Immunol., 69, 29, 10.1111/j.1365-3083.2008.02194.x

He, 2013, HMGB1 acts in synergy with lipopolysaccharide in activating rheumatoid synovial fibroblasts via p38 MAPK and NF-kappaB signaling pathways, Mediat. Inflamm., 2013, 596716, 10.1155/2013/596716

Hiscott, 2001, Hostile takeovers: viral appropriation of the NF-kappaB pathway, J. Clin. Invest., 107, 143, 10.1172/JCI11918

Huang, 2007, Extracellular hmgb1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection, Am. J. Transplant., 7, 799, 10.1111/j.1600-6143.2007.01734.x

Huebener, 2015, The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis, J. Clin. Invest., 125, 539, 10.1172/JCI76887

Hwang, 2016, HMGB1 modulation in pancreatic islets using a cell-permeable A-box fragment, J. Control. Release, 246, 155, 10.1016/j.jconrel.2016.12.028

Izushi, 2016, Soluble form of the receptor for advanced glycation end-products attenuates inflammatory pathogenesis in a rat model of lipopolysaccharide-induced lung injury, J. Pharmacol. Sci., 130, 226, 10.1016/j.jphs.2016.02.005

Jin, 2011, The effect of biodegradable gelatin microspheres on the neuroprotective effects of high mobility group box 1 A box in the postischemic brain, Biomaterials, 32, 899, 10.1016/j.biomaterials.2010.09.054

Kim, 2008, Expression, purification and characterization of TAT-high mobility group box-1A peptide as a carrier of nucleic acids, Biotechnol. Lett., 30, 1331, 10.1007/s10529-008-9695-4

Kokkola, 2003, Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity, Arthritis Rheum., 48, 2052, 10.1002/art.11161

Li, 2003, Structural basis for the proinflammatory cytokine activity of high mobility group box 1, Mol. Med., 9, 37, 10.1007/BF03402105

Li, 2014, RAGE/NF-kappaB pathway mediates lipopolysaccharide-induced inflammation in alveolar type I epithelial cells isolated from neonate rats, Inflammation, 37, 1623, 10.1007/s10753-014-9889-y

Li, 2015, High-mobility group box 1 accelerates lipopolysaccharide-induced lung fibroblast proliferation in vitro: involvement of the NF-kappaB signaling pathway, Lab. Investig., 95, 635, 10.1038/labinvest.2015.44

Lv, 2009, High-mobility group box 1 protein induces tissue factor expression in vascular endothelial cells via activation of NF-kappaB and Egr-1, Thromb. Haemost., 102, 352, 10.1160/TH08-11-0759

Matute-Bello, 2008, Animal models of acute lung injury, Am. J. Phys. Lung Cell. Mol. Phys., 295, L379

Mei, 2007, Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1, PLoS Med., 4, 10.1371/journal.pmed.0040269

Minamino, 2006, Regeneration of the endothelium as a novel therapeutic strategy for acute lung injury, J. Clin. Invest., 116, 2316, 10.1172/JCI29637

Murray, 2008, Deleterious role of TLR3 during hyperoxia-induced acute lung injury, Am. J. Respir. Crit. Care Med., 178, 1227, 10.1164/rccm.200807-1020OC

Oh, 2014, Combined delivery of HMGB-1 box A peptide and S1PLyase siRNA in animal models of acute lung injury, J. Control. Release, 175, 25, 10.1016/j.jconrel.2013.12.008

Song, 2016, Delivery of the high-mobility group box 1 box A peptide using heparin in the acute lung injury animal models, J. Control. Release, 234, 33, 10.1016/j.jconrel.2016.05.039

Thomas, 2001, HMG1 and 2: architectural DNA-binding proteins, Biochem. Soc. Trans., 29, 395, 10.1042/bst0290395

Uchida, 2006, Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury, Am. J. Respir. Crit. Care Med., 173, 1008, 10.1164/rccm.200509-1477OC

Wang, 2013, A novel hypothesis: up-regulation of HO-1 by activation of PPARgamma inhibits HMGB1-RAGE signaling pathway and ameliorates the development of ALI/ARDS, J. Thorac. Dis., 5, 706

Yamamoto, 2011, Septic shock is associated with receptor for advanced glycation end products ligation of LPS, J. Immunol., 186, 3248, 10.4049/jimmunol.1002253

Yang, 2012, Suppression of NF-kappaB pathway by crocetin contributes to attenuation of lipopolysaccharide-induced acute lung injury in mice, Eur. J. Pharmacol., 674, 391, 10.1016/j.ejphar.2011.08.029